Bugs&Drugs Profile
Bugs&Drugs

@NMatange

Followers
1K
Following
2K
Media
7
Statuses
394

Microbiologist interested in bacterial adaptation to antibiotics

Pune, India
Joined March 2019
Don't wanna be here? Send us removal request.
@SutirthDey
Sutirth Dey
6 days
AI in Research_A User's Perspective Workshop_Why choose this workshop? Link to the second video with the workshop details: https://t.co/fG3kV1f00F The website is here: https://t.co/OXtK2c9euz
3
16
20
@iamamardeeep
Amar Deep
17 days
Are you curious about how bacteria defend themselves against viral attacks? Our lab at IISER Mohali explores these molecular defense pathways and their potential to inspire new biotechnological tools. Interested candidates can apply here: https://t.co/JecS3Pvqqb
0
9
20
@NMatange
Bugs&Drugs
19 days
Bottomline: Our study highlights that targeting intrinsic resistance pathways, such as efflux, can be useful to ‘resistance proof’. Yet, the gap between genetic and pharmacological inhibition is likely to be a major challenge in the application of this approach as a therapeutic.
1
0
1
@NMatange
Bugs&Drugs
19 days
When we try to recapitulate these findings with pharmacological inhibition using an Efflux Pump Inhibitor (EPI), E. coli pulls out another trick from its bag of adaptive strategies. Its fixes mutations in transcriptional regulators to adapt to the EPI-Antibiotic combination.
1
0
0
@NMatange
Bugs&Drugs
19 days
We then use laboratory evolution of trimethoprim resistance to show that impeding efflux can also significantly compromise the ability to E. coli to adapt to antibiotic. This is mechanistically explained by the dampened benefit of adaptive mutations in efflux-deficient bacteria.
1
0
0
@NMatange
Bugs&Drugs
19 days
We then ask how effectively impeding two well known pathways, drug efflux through AcrAB-TolC and LPS biosynthesis, reduces the MIC of resistant strains. Efflux emerges as the clear winner from our data, across antibiotic and mutant combinations.
1
0
0
@NMatange
Bugs&Drugs
19 days
We start by screening the Keio mutant collection for single gene knockouts that are hypersensitive to trimethoprim and chloramphenicol. Both broad spectrum antimicrobials. We discover some new targets, in addition to re-discovering many usual suspects.
1
0
0
@NMatange
Bugs&Drugs
19 days
Out now at @PLOSBiology we evaluate the potential for antibiotic efflux and cell wall biogenesis as targets for reversing drug resistance and preventing its de novo evolution in Escherichia coli. Link below: https://t.co/oeQ71wxFTJ
Tweet card summary image
journals.plos.org
Intrinsic resistance pathways in E. coli can be exploited to enhance antibiotic sensitivity and limit resistance evolution. This study shows that genetic inhibition of efflux pumps and cell envelope...
17
9
68
@AdhesionLab
Nagaraj Balasubramanian
1 month
APPLICATIONS are NOW OPEN Jan 2026 PhD intake at the Department of Biology @IISERPune Submission Deadline: 5pm - OCT 23, 2025. For details, check the link below https://t.co/yPNngzWmxj
2
24
65
@swaminathaniisc
Sundar Swaminathan
4 months
Tata IISc Medical School in Bangalore is currently hiring faculty. More information can be found here: https://t.co/4Uezh0nMhX. You can join the online event on July 26 to find out more. Please register here for link: https://t.co/y43A5giPy5. Please kindly share in your groups.
2
8
19
@GeneticsGSA
Genetics Society of America
5 months
New research in #GENETICS from @NMatange and colleagues showcases canonical and non-canonical strategies employed by #Ecoli to survive in low levels of spectinomycin that facilitate genetic adaptation for acquiring antibiotic resistance. Read more: https://t.co/8PlHyIekUU
0
1
4
@eLife
eLife - the journal
5 months
Not all persister bacteria are dormant! 🦠 Single-cell imaging of over a million #EColi shows that many antibiotic-resistant persisters were actively growing before drug exposure. Persistence appears to be more dynamic than once thought. https://t.co/KiXy38xOAY
0
2
16
@NMatange
Bugs&Drugs
6 months
Thanks to @GeneticsGSA for excellent and rigorous reviews. Thanks to the @India_Alliance for generous funding.
1
0
1
@NMatange
Bugs&Drugs
6 months
Digging deeper led us to identify some interesting links between proton/PMF homeostasis and antibiotic susceptibility. Kudos to Chinmaya @imcjena16 and his trusty accomplice @DeolankarSoham this one was no less than a Holmes mystery!
1
0
1
@NMatange
Bugs&Drugs
6 months
Chinmaya exposed E.coli to low levels of an environmentally relevant antibiotic, Spectinomycin. He asked if resistance is the only kind of adaptation possible. Turns out there are mutations that allow low drug specific adaptations but don’t alter antibiotic MIC values.
0
0
1
@Saritapuri24
Sarita
6 months
This is indeed a serious concern. Please intervene @IndiaDST @DrJitendraSingh @PMOIndia
@NeelimaSayali
Sayali Atkare
6 months
@IndiaDST @DrJitendraSingh @karandi65 We are fellows of DST-INSPIRE Fellowship in India, not recieving any amounts from last 13+ months, barely surviving and struggling to make our ends meet. No clear answers, no timelines on enquiring. @narendramodi Sir, please intervene.
0
2
4
@AdhesionLab
Nagaraj Balasubramanian
6 months
Special Call for PhD intake in Biology @IISERPune This is for Dec 2024 CSIR-UGC-NET qualified candidates, whose results were recently announced. Check out details on the IISER website. The flyer lists labs taking students. Look up labs, too. Kindly RT. https://t.co/yPNngzVOHL
1
17
24
@ChabaRachna
Rachna Chaba
8 months
We have 2-3 Ph.D. positions in https://t.co/izg7N6O9BD @IISERMohali. Students interested in understanding how bacteria sense & adapt to nutrient availability & stress conditions, please apply. Deadline: April 10
Tweet card summary image
chabalab.org
Metabolism, Stress Responses, Gene Regulation
2
28
119
@eLife
eLife - the journal
8 months
1/ The Trump administration is throwing science and scientists into turmoil – how should the scientific community respond? Read the latest opinion pieces below from our new collection: ‘Science Under Threat in the US’ https://t.co/wdsKkfKj4s
Tweet card summary image
elifesciences.org
The new administration in the US is conducting an assault on science and scientists – how should the scientific community respond?
3
11
29